Corrigendum to: High Glucose and Glucose-derived Intermediates are Linked to Lung Cancer Aggressiveness

In the above-mentioned article published in Current Cancer Drug Targets, 2026, 26(4), 393-395, the citation for Fig. (1) was inadvertently omitted. The original article can be found online at: https://www.benthamscience.com/article/150331 Details of the correction are as follows: Original: These findings suggested that the metabolic features associated with metastasis could be utilized as potential therapeutic targets. The authors proposed that, for cancer cells, oxidative metabolism could play an ad-vantageous role in the process of metastasis. However, the exact molecular events underlying increased metastatic burden are unclear and require further investi-gation. Corrected: These findings suggested that the metabolic features associated with metastasis could be utilized as potential therapeutic targets. The authors proposed that, for cancer cells, oxidative metabolism could play an ad-vantageous role in the process of metastasis. However, the exact molecular events underlying increased metastatic burden are unclear and require further investigation (Fig. 1).